BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen A, Böttger R, Li SD. Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials. Biomaterials 2021;275:120955. [PMID: 34130143 DOI: 10.1016/j.biomaterials.2021.120955] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Zong Q, Zhao Z, Yuan Y. A dual-amplified ROS-responsive nanosystem with self-accelerating drug release for synergistic chemotherapy. Chem Commun (Camb) 2023;59:3142-5. [PMID: 36811610 DOI: 10.1039/d3cc00052d] [Reference Citation Analysis]
2 Zhou S, Zhao W, Hu J, Mao C, Zhou M. Application of Nanotechnology in Thrombus Therapy. Adv Healthc Mater 2023;12:e2202578. [PMID: 36507827 DOI: 10.1002/adhm.202202578] [Reference Citation Analysis]
3 Sun X, Xu X, Wang J, Zhang X, Zhao Z, Liu X, Wang G, Teng L, Chen X, Wang D, Li Y. Acid-switchable nanoparticles induce self-adaptive aggregation for enhancing antitumor immunity of natural killer cells. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.002] [Reference Citation Analysis]
4 Sun Y, Wang S, Li Y, Wang D, Zhang Y, Zhang H, Lei H, Liu X, Sun J, Sun B, He Z. Precise engineering of disulfide bond-bridged prodrug nanoassemblies to balance antitumor efficacy and safety. Acta Biomater 2023;157:417-27. [PMID: 36513247 DOI: 10.1016/j.actbio.2022.12.005] [Reference Citation Analysis]
5 Zhong ZX, Li XZ, Liu JT, Qin N, Duan HQ, Duan XC. Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy. Int J Nanomedicine 2023;18:1281-98. [PMID: 36945256 DOI: 10.2147/IJN.S404848] [Reference Citation Analysis]
6 Lu Y, Gao Y, Yang H, Hu Y, Li X. Nanomedicine-boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma. Mil Med Res 2022;9:69. [PMID: 36503490 DOI: 10.1186/s40779-022-00433-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
7 Qian X, Xia C, Chen X, Li Q, Li D. Self-assembled amphiphilic copolymers-doxorubicin conjugated nanoparticles for gastric cancer therapy with low in vivo toxicity and high efficacy. J Biomater Sci Polym Ed 2022;33:2202-19. [PMID: 35924948 DOI: 10.1080/09205063.2022.2100024] [Reference Citation Analysis]
8 Wang S, Song Y, Ma J, Chen X, Guan Y, Peng H, Yan G, Tang R. Dynamic crosslinked polymeric nano-prodrugs for highly selective synergistic chemotherapy. Asian J Pharm Sci 2022;17:880-91. [PMID: 36600901 DOI: 10.1016/j.ajps.2022.09.004] [Reference Citation Analysis]
9 Zhang Z, Lao T, Deng L, Zhang C, Liu J, Fu M, Su Z, Yu Y, Cao H. Mechanochemical Electrophilic Mono- or Disulfur Transfer: Construction of P(O)-S or P(O)-S-S Bonds. Org Lett 2022. [PMID: 36169201 DOI: 10.1021/acs.orglett.2c03018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Li X, Sun H, Lu Y, Xing L. Radiotherapy-triggered prodrug activation: A new era in precise chemotherapy. Med (N Y) 2022;3:600-2. [PMID: 36087574 DOI: 10.1016/j.medj.2022.08.004] [Reference Citation Analysis]
11 Nguyen A, Chao P, Ong CY, Rouhollahi E, Fayez NA, Lin L, Brown JI, Böttger R, Page B, Wong H, Li S. Chemically engineering the drug release rate of a PEG-paclitaxel conjugate using click and steric hindrance chemistries for optimal efficacy. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121735] [Reference Citation Analysis]
12 Seidi F, Zhong Y, Xiao H, Jin Y, Crespy D. Degradable polyprodrugs: design and therapeutic efficiency. Chem Soc Rev 2022. [PMID: 35796314 DOI: 10.1039/d2cs00099g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Sun L, Zhao P, Chen M, Leng J, Luan Y, Du B, Yang J, Yang Y, Rong R. Taxanes prodrug-based nanomedicines for cancer therapy. J Control Release 2022;348:672-91. [PMID: 35691501 DOI: 10.1016/j.jconrel.2022.06.004] [Reference Citation Analysis]
14 Dong X, Brahma RK, Fang C, Yao SQ. Stimulus-responsive self-assembled prodrugs in cancer therapy. Chem Sci 2022;13:4239-69. [PMID: 35509461 DOI: 10.1039/d2sc01003h] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
15 Yin W, Wang Y, Xiao Y, Mao A, Lang M. Phenylboronic acid conjugated mPEG-b-PCL micelles as DOX carriers for enhanced drug encapsulation and controlled drug release. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111235] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Wang Q, Wang C, Li S, Xiong Y, Wang H, Li Z, Wan J, Yang X, Li Z. Influence of Linkers within Stimuli-Responsive Prodrugs on Cancer Therapy: A Case of Five Doxorubicin Dimer-Based Nanoparticles. Chem Mater . [DOI: 10.1021/acs.chemmater.1c03346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Tang L, Mei Y, Shen Y, He S, Xiao Q, Yin Y, Xu Y, Shao J, Wang W, Cai Z. Nanoparticle-Mediated Targeted Drug Delivery to Remodel Tumor Microenvironment for Cancer Therapy. Int J Nanomedicine 2021;16:5811-29. [PMID: 34471353 DOI: 10.2147/IJN.S321416] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]